Evidence map›Paper›PMID 36121152›Full record

ArticlemBio2022

High Glucose and Carbonyl Stress Impair HIF-1-Regulated Responses and the Control of Mycobacterium tuberculosis in Macrophages.

Graciela Terán, Hanxiong Li, Sergiu-Bogdan Catrina, Ruining Liu, Susanna Brighenti, Xiaowei Zheng, Jakob Grünler, Susanne Nylén, Berit Carow, Martin E Rottenberg

Open access · goldAbstract read
In one paragraph

Article in mBio, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed, 1 pooled it
2.1field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 1 synthesis or guideline pooled it, 25 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. A putativeFrontiers in immunology · 2026
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Review
  14. Article
  15. Metabolic flux reprogramming inFrontiers in microbiology · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Graciela Terán *Department of Microbiology, Tumor and Cell Biology (MTC), Karolinska Institutegrid.4714.6t, Stockholm Sweden.
Hanxiong Li *Department of Microbiology, Tumor and Cell Biology (MTC), Karolinska Institutegrid.4714.6t, Stockholm Sweden.
Sergiu-Bogdan CatrinaDepartment of Molecular Medicine and Surgery, Karolinska Institutegrid.4714.6t, Rolf Luft Research Center for Diabetes and Endocrinology, Karolinska University Hospital, Stockholm, Sweden.
Ruining LiuDepartment of Microbiology, Tumor and Cell Biology (MTC), Karolinska Institutegrid.4714.6t, Stockholm Sweden.
Susanna BrighentiCenter for Infectious Medicine (CIM), Department of Medicine, Karolinska Institutegrid.4714.6t, Stockholm, Sweden.
Xiaowei ZhengDepartment of Molecular Medicine and Surgery, Karolinska Institutegrid.4714.6t, Rolf Luft Research Center for Diabetes and Endocrinology, Karolinska University Hospital, Stockholm, Sweden.
Jakob GrünlerDepartment of Molecular Medicine and Surgery, Karolinska Institutegrid.4714.6t, Rolf Luft Research Center for Diabetes and Endocrinology, Karolinska University Hospital, Stockholm, Sweden.
Susanne NylénDepartment of Microbiology, Tumor and Cell Biology (MTC), Karolinska Institutegrid.4714.6t, Stockholm Sweden.
Berit CarowDepartment of Microbiology, Tumor and Cell Biology (MTC), Karolinska Institutegrid.4714.6t, Stockholm Sweden.
Martin E RottenbergDepartment of Microbiology, Tumor and Cell Biology (MTC), Karolinska Institutegrid.4714.6t, Stockholm Sweden.ORCID 0000-0003-0514-7434
Karolinska Institutet · SEKarolinska University Hospital · SE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Diabetes mellitus (DM) increases the risk of developing tuberculosis (TB), but the mechanisms behind diabetes-TB comorbidity are still undefined. Here, we studied the role of hypoxia-inducible factor-1 (HIF-1), a main regulator of metabolic and inflammatory responses, in the outcome of Mycobacterium tuberculosis infection of bone marrow-derived macrophages (BMM). We observed that M. tuberculosis infection of BMM increased the expression of HIF-1α and HIF-1-regulated genes. Treatment with the hypoxia mimetic deferoxamine (DFO) further increased levels of HIF-1-regulated immune and metabolic molecules and diminished the intracellular bacterial load in BMM and in the lungs of infected mice. The expression of HIF-1-regulated immunometabolic genes was reduced, and the intracellular M. tuberculosis levels were increased in BMM incubated with high-glucose levels or with methylglyoxal (MGO), a reactive carbonyl compound elevated in DM. In line with the

Indexed as

Mycobacterium tuberculosisTuberculosisAnimalsDeferoxamineGlucoseHypoxiaHypoxia-Inducible Factor 1MacrophagesMagnesium OxideMicePyruvaldehydeDeferoxamineGlucoseHypoxia-Inducible Factor 1Magnesium OxidePyruvaldehydediabetesHIF-1macrophageMycobacterium tuberculosis

Identifiers

PMID36121152
PMCPMC9600926
OpenAlexW4296325562

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.